Suppr超能文献

实验性膜性肾病中肾小球前列腺素生成增加。

Enhanced glomerular prostaglandin formation in experimental membranous nephropathy.

作者信息

Stahl R A, Adler S, Baker P J, Chen Y P, Pritzl P M, Couser W G

出版信息

Kidney Int. 1987 May;31(5):1126-31. doi: 10.1038/ki.1987.118.

Abstract

To determine whether the induction of immune-mediated glomerular injury influences the formation of cyclooxygenase products by glomerular cells, we determined prostaglandin E2 (PGE2) and thromboxane B2 (TXB2) (as the stable metabolite of TXA2) formation in isolated glomeruli of rats with passive Heymann nephritis (PHN). PHN is a model of membranous nephropathy mediated by antibody and complement independent of inflammatory cells. Five days following induction of PHN by injection of heterologous antibody to rat proximal tubular brush border antigen (Fx1A) rats developed proteinuria 36.5 +/- 34 (controls 3.8 +/- 1 mg/day). Treatment with cobra venom factor, which depleted complement C3 levels to less than 10% of baseline, prevented the development of proteinuria (6.9 +/- 2 mg/day). The development of subepithelial, glomerular immune-complex deposits and proteinuria was associated with a significant stimulation of glomerular PGE2 (87%) and TXB2 (183%) formation. This increment in glomerular prostanoid biosynthesis was significantly inhibited (PGE2 increased 22%, TXB2 increased 75%) in animals that were complement depleted with cobra venom factor. Cobra venom factor had no effect on glomerular prostanoid formation in normal rats. In additional experiments we tested the hypothesis that TXA2 may contribute to mediation of proteinuria in PHN. We utilized a thromboxane synthetase inhibitor UK38485. UK38485 reduced glomerular TXB2 formation by 80% without influencing glomerular deposition of 125I-labeled antibody, and did not alter levels of urine protein excretion in rats with PHN (control 42 +/- 21, UK 38485, 39 +/- 24 mg/day, P greater than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为了确定免疫介导的肾小球损伤的诱导是否会影响肾小球细胞中环氧化酶产物的形成,我们测定了被动型海曼肾炎(PHN)大鼠分离肾小球中前列腺素E2(PGE2)和血栓素B2(TXB2,作为血栓素A2的稳定代谢产物)的形成。PHN是一种由抗体和补体介导的膜性肾病模型,不依赖炎症细胞。通过注射抗大鼠近端肾小管刷状缘抗原(Fx1A)的异源抗体诱导PHN五天后,大鼠出现蛋白尿,为36.5±34(对照组为3.8±1mg/天)。用眼镜蛇毒因子治疗使补体C3水平降至基线的10%以下,可预防蛋白尿的发生(6.9±2mg/天)。上皮下肾小球免疫复合物沉积和蛋白尿的发生与肾小球PGE2(87%)和TXB2(183%)形成的显著刺激有关。在经眼镜蛇毒因子补体耗竭的动物中,这种肾小球类前列腺素生物合成的增加受到显著抑制(PGE2增加22%,TXB2增加75%)。眼镜蛇毒因子对正常大鼠的肾小球类前列腺素形成没有影响。在另外的实验中,我们检验了血栓素A2可能参与介导PHN蛋白尿的假说。我们使用了血栓素合成酶抑制剂UK38485。UK38485使肾小球TXB2的形成减少80%,而不影响125I标记抗体的肾小球沉积,并且不改变PHN大鼠的尿蛋白排泄水平(对照组42±21,UK38485组39±24mg/天,P>0.05)。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验